Celgene News
Most Popular Celgene Story
UPDATED: Celgene snaps up Avila Therapeutics in $925M buyout
In less than five years Avila Therapeutics nailed down a reputation as an exciting developer of covalent drugs, with a lead Btk inhibitor for cancer garnering attention at a very early stage of Read more...
Latest Headlines
- January 26, 2012
- January 6, 2012
- November 17, 2011
- November 8, 2011
- November 22, 2010
- October 7, 2010
- June 30, 2010
- April 15, 2010
- April 9, 2010
- April 7, 2010
- December 16, 2009
- December 8, 2009
- December 8, 2009
- September 2, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
